Chang Jingyue, Zhang Lingquan, Li Zeting, Qian Chungen, Du Juan
School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, Guangdong, China.
Department of Reagent Research and Development, Shenzhen YHLO Biotech Co., Ltd., Shenzhen 518172, Guangdong, China.
Biochim Biophys Acta Rev Cancer. 2024 Nov;1879(6):189188. doi: 10.1016/j.bbcan.2024.189188. Epub 2024 Sep 21.
Exosomes, extracellular vesicles carrying a cargo rich in various non-coding RNAs (ncRNAs), have emerged as crucial mediators of intercellular communication. Their stability, abundance, and specificity make exosomal ncRNAs promising candidates for biomarker discovery. The discovery of exosomal ncRNAs has unveiled a novel avenue for the exploration of biomarkers in tumor early diagnosis. This review consolidates current knowledge on the role of exosomal ncRNAs as potential biomarkers in the early detection of various tumors. We provide an overview of recent studies demonstrating the diagnostic potential of exosomal ncRNAs across multiple cancer types, highlighting their sensitivity, specificity, and feasibility for early detection. This review underscores the potential of exosomal ncRNAs as non-invasive biomarkers for early tumor diagnosis, paving the way for improved clinical outcomes through timely intervention and personalized management strategies.
外泌体是携带丰富各种非编码RNA(ncRNAs)货物的细胞外囊泡,已成为细胞间通讯的关键介质。它们的稳定性、丰度和特异性使外泌体ncRNAs成为生物标志物发现的有前途的候选者。外泌体ncRNAs的发现为肿瘤早期诊断中生物标志物的探索开辟了一条新途径。本综述整合了当前关于外泌体ncRNAs作为各种肿瘤早期检测潜在生物标志物作用的知识。我们概述了最近的研究,这些研究证明了外泌体ncRNAs在多种癌症类型中的诊断潜力,强调了它们在早期检测中的敏感性、特异性和可行性。本综述强调了外泌体ncRNAs作为早期肿瘤诊断的非侵入性生物标志物的潜力,为通过及时干预和个性化管理策略改善临床结果铺平了道路。